In today’s briefing:
- Automobile Industry FY25: Expectations for Different Verticals
- Chinese Banks Relax Loan Terms to Fuel Tech Sector M&A Deals
- RBI’s Overhaul of India’s Priority Sector Lending Norms
- AI Boom Puts Pressure on China’s Power Grid as Data Centers Eat Up Electricity
- APAC Healthcare Weekly (Mar 30)- Eisai, Kaken, Mochida, Shionogi, SK Bioscience, PharmaEssentia
Automobile Industry FY25: Expectations for Different Verticals
- Automobile industry is expected to witness a mixed performance in FY25 Volume growth, with robust growth in tractors, moderate increases in 2W’s and PV’s, and a slight decline in CV’s
- Favorable farmer sentiment driving tractor demand and substantial export opportunities for 2W’s are key growth triggers anticipated.
- Escorts Kubota Limited (ESCORTS IN) with a revenue share of 80% from tractor business, foresees significant growth driven by a robust domestic market and double-digit growth in their export business.
Chinese Banks Relax Loan Terms to Fuel Tech Sector M&A Deals
- Several Chinese banks have handed out loans to support selected tech firms’ merger-and-acquisition (M&A) deals under a newly launched pilot program to improve access to credit for innovative businesses.
- China Construction Bank, one of the country’s biggest state-owned lenders, has issued 190 million yuan ($26.3 million) in an M&A loan to a publicly listed tech firm in Suzhou, Jiangsu province, people familiar with the deal told Caixin.
- The loan, covering 80% of the acquisition cost with an eight-year term, is the first loan of this type disbursed by a large state bank after the easing M&A loan policies by financial regulators to help tech enterprises.
RBI’s Overhaul of India’s Priority Sector Lending Norms
- RBI has expanded PSL norms higher loan limits, broader beneficiary definitions, and new incentives to push credit into underserved sectors and geographies.
- This modernizes India’s financial inclusion framework, aligns credit policy with inflation, green goals, and gender inclusion, and reduces compliance friction for banks.
- PSL is evolving into a growth lever, not just a mandate impacting loan strategies, certificate pricing, and long-term retail credit profitability for banks and fintechs.
AI Boom Puts Pressure on China’s Power Grid as Data Centers Eat Up Electricity
- China’s rapidly expanding artificial intelligence (AI) industry is eating up electricity at an alarming rate — a factor analysts say could disrupt the country’s power grid if infrastructure doesn’t keep pace.
- By 2035, China’s data centers will consume 400 billion kilowatt-hours (kWh) of electricity a year — around four times their 2024 usage, Bloomberg analyst Lv Jinghong estimated at the BloombergNEF Summit in Beijing Thursday.
- That will account for 3.2% of national power consumption, comparable to the entire electricity usage of Sichuan province.
APAC Healthcare Weekly (Mar 30)- Eisai, Kaken, Mochida, Shionogi, SK Bioscience, PharmaEssentia
- Eisai is eyeing for Leqembi global revenue of ¥250–280B in FY28. Kaken Pharmaceutical inlicensed dermatology drug candidate from Alumis. Kaken’s onychomycosis drug got approval in Italy.
- Mochida Pharmaceutical has applied for marketing approval of Actembra biosimilar in Japan. Shionogi has filed for indication expansion of Xocova for post-exposure prophylaxis of COVID-19 in Japan.
- SK Bioscience got approval for Phase 3 clinical trial of 21-valent pneumococcal vaccine in European countries. PharmaEssential obtained approval for Phase 3 clinical trial of Ropeginterferon alfa-2b in China.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
Unlock all research summaries